Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk.

Saved in:
Bibliographic Details
Title: Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk.
Authors: Chapman MJ; Dyslipidemia, Inflammation and Atherosclerosis Research Unit, UMR-S939, National Institute for Health and Medical Research (INSERM), Hôpital de la Pitié-Salpetriere, Paris, France. john.chapman@upmc.fr, Redfern JS, McGovern ME, Giral P
Source: Pharmacology & therapeutics [Pharmacol Ther] 2010 Jun; Vol. 126 (3), pp. 314-45. Date of Electronic Publication: 2010 Feb 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 7905840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-016X (Electronic) Linking ISSN: 01637258 NLM ISO Abbreviation: Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 20153365
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chapman+MJ%22">Chapman MJ</searchLink>; Dyslipidemia, Inflammation and Atherosclerosis Research Unit, UMR-S939, National Institute for Health and Medical Research (INSERM), Hôpital de la Pitié-Salpetriere, Paris, France. john.chapman@upmc.fr<br /><searchLink fieldCode="AU" term="%22Redfern+JS%22">Redfern JS</searchLink><br /><searchLink fieldCode="AU" term="%22McGovern+ME%22">McGovern ME</searchLink><br /><searchLink fieldCode="AU" term="%22Giral+P%22">Giral P</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227905840%22">Pharmacology & therapeutics</searchLink> [Pharmacol Ther] 2010 Jun; Vol. 126 (3), pp. 314-45. <i>Date of Electronic Publication: </i>2010 Feb 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pergamon+Press%22">Pergamon Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7905840 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-016X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201637258%22">01637258 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20153365
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.pharmthera.2010.01.008
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 314
    Titles:
      – TitleFull: Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chapman MJ
      – PersonEntity:
          Name:
            NameFull: Redfern JS
      – PersonEntity:
          Name:
            NameFull: McGovern ME
      – PersonEntity:
          Name:
            NameFull: Giral P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2010 Jun
              Type: published
              Y: 2010
          Identifiers:
            – Type: issn-electronic
              Value: 1879-016X
          Numbering:
            – Type: volume
              Value: 126
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Pharmacology & therapeutics
              Type: main
ResultId 1